Transcription of Public Assessment Report Repeat-Use Mutual Recognition ...
{{id}} {{{paragraph}}}
Public Assessment Report Repeat-Use Mutual Recognition Procedure VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03 UK Licence No: PL 21727/0016-0017 Grunenthal Limited MRPAR Versatis/Lidocaine 5% Medicated Plaster UK/H/1040-1041/001/E03 2 LAY SUMMARY VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (lidocaine) This is a summary of the Public Assessment Report (PAR) for Versatis/Lidocaine 5% Medicated Plaster (PL 21727/0016-0017). It explains how Versatis/Lidocaine 5% Medicated Plaster w as assessed and its authorisation recommended, as well as its conditions of use.
Public Assessment Report . Repeat-Use Mutual Recognition Procedure . VERSATIS 5% MEDICATED PLASTER . LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}